Philadelphia’s Office of Business Development awarded $450,000 in matching grants to 21 life sciences companies, the first ...

While GLP-1 (glucagon-like peptide-1) class obesity treatments like ‘Wegovy’ and ‘Mounjaro’ have gained immense popularity, ...

The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at ...

Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and ...

XI'AN CITY, SHAANXI PROVINCE, CHINA, January 21, 2026 /EINPresswire.com/ -- The global nootropics and wellness ...

For this list, we screened for S&P 500 companies with a market cap of at least $10 billion and identified stable dividend ...

Dow Jones Top Company Headlines at 9 PM ET: Merck No Longer in Talks to Buy Revolution Medicines | The ... The drugmaker had recently been in discussions to acquire RevMed in a deal that could have ...

Shares of Qiagen have rebounded after three years following a news report that the provider of biotech workflow solutions was evaluating strategic options, which include a potential sale.

Global institutional investors have built up sizeable positions in firms including Innovent, 3SBio, WuXi Biologics, Jiangsu ...

Dayo Adu, the inaugural chairman of the Healthcare & Pharmaceuticals Law Committee of the Nigerian Bar Association Section ...

The need to address the high cost of prescription drugs is one of the rare areas of concordance in our divided country. Americans across the political spectrum can agree that seniors shouldn’t have to ...

Genentech, a San Francisco-based biotech company, has decided to more than double its investment in a new drug manufacturing facility in North Carolina.